Authors: Bergstrom, JD Nilsson, M Heldin, NE

Citation: Jd. Bergstrom et al., Impaired response to hepatocyte growth factor in FRTL-5 rat thyroid cells expressing a functional hepatocyte growth factor receptor, THYROID, 10(8), 2000, pp. 631-640

Authors: Detmers, PA Hernandez, M Mudgett, J Hassing, H Burton, C Mundt, S Chun, S Fletcher, D Card, DJ Lisnock, J Weikel, R Bergstrom, JD Shevell, DE Hermanowski-Vosatka, A Sparrow, CP Chao, YS Rader, DJ Wright, SD Pure, E

Citation: Pa. Detmers et al., Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice, J IMMUNOL, 165(6), 2000, pp. 3430-3435

Authors: Wright, SD Burton, C Hernandez, M Hassing, H Montenegro, J Mundt, S Patel, S Card, DJ Hermanowski-Vosatka, A Bergstrom, JD Sparrow, CP Detmers, PA Chao, YS

Citation: Sd. Wright et al., Infectious agents are not necessary for murine atherogenesis, J EXP MED, 191(8), 2000, pp. 1437-1441

Authors: Bergstrom, JD Westermark, B Heldin, NE

Citation: Jd. Bergstrom et al., Epidermal growth factor receptor signaling activates Met in human anaplastic thyroid carcinoma cells, EXP CELL RE, 259(1), 2000, pp. 293-299

Authors: Bergstrom, JD Bostedor, RG Masarachia, PJ Reszka, AA Rodan, G

Citation: Jd. Bergstrom et al., Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase, ARCH BIOCH, 373(1), 2000, pp. 231-241

Authors: Bergstrom, JD Hermansson, A de Stahl, TD Heldin, NE

Citation: Jd. Bergstrom et al., Non-autocrine, constitutive activation of Met in human anaplastic thyroid carcinoma cells in culture, BR J CANC, 80(5-6), 1999, pp. 650-656